ArticleFoods (Basel, Switzerland)2026
Dietary Exposure and Risk Assessment for L-Ergothioneine in China.
Article in Foods (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Gut microbiota-derived ergothioneine: a promising neuroprotective metabolite against antipsychotic-induced cognitive decline.Precision clinical medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
L-Ergothioneine (L-EGT), a naturally occurring thiol compound abundant mainly in edible fungi, is increasingly regarded as a potentially beneficial bioactive constituent. However, population-level exposure data remain limited. This study aimed to estimate background dietary exposure to L-EGT among Chinese residents, describe its distribution across population subgroups and regions, identify major food contributors, and characterize the risk using a margin of exposure (MOE) approach. Individual body-weight-normalized L-EGT intakes were estimated from published food concentration data and three-day dietary recalls of 42,218 participants. MOEs were calculated using a no observed adverse effect level (NOAEL) of 800 mg/kg bw/d obtained from subchronic toxicity studies. The mean dietary exposure to L-EGT was 0.043 mg/kg bw/d (MOE = 18,605) in the general population and 0.174 mg/kg bw/d (MOE = 4598) among consumers, with 95th percentile exposures of 0.244 mg/kg bw/d (MOE = 3279) and 0.644 mg/kg bw/d (MOE = 1242), respectively. MOE values were consistently above the safety threshold of 300 across all subgroups, with less than 0.3% of the total population and 1.3% of consumers aged 3-6 years falling below this value. These results indicate that current natural dietary exposure to L-EGT in China is low and does not raise safety concerns and provide essential baseline data for future studies on its health effects, optimal intake ranges, and long-term safety.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.